Related Experiment Video
Updated: Jul 19, 2026

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
Published on: August 16, 2021
Medical treatment of patients with heart failure or left ventricular dysfunction undergoing percutaneous coronary
Michael J Lipinski1, George W Vetrovec
1Division of Cardiology, Medical College of Virginia Campus of Virginia Commonwealth University, Richmond, Virginia, USA.
Insights
This review outlines a management strategy for ischemic heart patients with left ventricular (LV) dysfunction, focusing on percutaneous coronary intervention (PCI) timing and optimal medications to improve outcomes.
Area of Science:
- Cardiology
- Interventional Cardiology
- Heart Failure Management
Background:
- Ischemic patients with left ventricular (LV) dysfunction present complex management challenges.
- Optimizing outcomes while minimizing risk requires careful consideration of percutaneous coronary intervention (PCI) timing and adjunctive medications.
Purpose of the Study:
- To provide a systematic management scheme for patients with heart failure or LV dysfunction presenting with various ischemic syndromes.
- To offer evidence-based recommendations for medication use before, during, and after PCI.
Main Methods:
- Systematic review of therapeutic approaches for acute or decompensated heart failure.
- Analysis of coronary angiography timing based on ischemia severity.
- Evidence-based recommendations for pharmacotherapy in PCI management.
Main Results:
- A structured approach to managing ischemic heart failure patients undergoing PCI.
- Guidance on selecting appropriate adjunctive medications to enhance treatment efficacy.
- Recommendations for timing of invasive procedures based on clinical presentation and ischemic burden.
Conclusions:
- A comprehensive management strategy is crucial for ischemic patients with LV dysfunction undergoing PCI.
- Tailored pharmacotherapy and procedural timing can significantly improve patient outcomes.
- This review provides a framework for evidence-based decision-making in complex cardiovascular cases.
Abstract:
Management of ischemic patients with pre-existing or new-onset left ventricular (LV) dysfunction poses a special challenge in terms of the timing of percutaneous coronary intervention (PCI) and appropriate adjunctive medications to optimize outcome while minimizing risk. In a systematic fashion, this review attempts to provide a management scheme for patients with heart failure or LV dysfunction that present with stable angina, ST-segment elevation myocardial infarction, or unstable angina/non-ST-segment elevation myocardial infarction. By addressing therapeutic approaches to acute or decompensated heart failure and timing of coronary angiography based on severity of ischemia, we provide evidence-based recommendations for medications to initiate before, during, and following PCI.
Related Concept Videos
Heart Failure VI: Adjunct Therapies
Cardiomyopathy V: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care
Heart Failure V: Medical Management
Cardiac Catheterization III: Left Heart Catheterization
